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A cysteine endopeptidase, named funastrain c II, was isolated and characterized from the latex
of Funastrum clausum (Asclepiadaceae). The molecular mass (mass spectrometry) of the
protease was 23.636 kDa. The analysis of funastrain c II by SDS-PAGE revealed a single polypep-
tide chain. The enzyme showed a remarkable stability of its caseinolytic activity after incubation
at temperatures as high as 70°C. Inhibition and activation assays indicated the cysteinic nature
of the funastrain c II catalytic site. The optimum pH of funastrain c II enzymatic activity varied
according to the substrate used (9.0–10.0 for casein and 6.2–6.8 for PFLNA). Kinetic parameters
were determined for N-α-CBZ-Ala p-nitrophenyl ester (Km  0.0243 mM, kcat  1.5 s–1) and
L-pyroglutamyl-L-phenylalanyl-L-leucine-p-nitroanilide (PFLNA; KM  0.1011 mM, kcat 
0.9 s–1). The N-terminal sequence of funastrain c II showed considerable similarity to other
proteases isolated from latex of different Asclepiadaceae species as well as to other cysteine
proteinases belonging to the papain family.
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1. INTRODUCTION
Several plant cysteine proteases from latex have been
reported. Latex of Carica papaya (Glazer and Smith,
1971; Lynn, 1979; Robinson, 1975), Ficus carica
(Kramer and Whitaker, 1964; Sgarbieri et al., 1964;
Sugiura and Sasaki, 1974), Ficus glabrata (Englund
et al., 1968; Jones and Glazer, 1970; Kortt et al., 1974a,
1974b; Williams and Whitaker, 1969), Ficus pumila
(Perelló et al., 2000), Carica candamarcensis (Gravina
de Moraes et al., 1994), Calotropis procera (Dubey and
Jagannadham, 2003), and of Ervatamia coronaria
(Kundu et al., 2000) contains distinct cysteine proteases.
The precise biological role of these cysteine proteases
still remains uncertain, but by virtue of the broad sub-
strate specificity they show, it is supposed that they
might protect ripening fruits against plant pathogens,
especially fungi and insects (Baker and Drenth, 1987).
Plant cysteine proteinases, such as papain, brome-
lain, and ficin, are extensively used in many industrial
processes. They have been exploited commercially in
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food industry for meat tenderizing (to separate partially
connective tissues), brewing (to solubilize grain pro-
teins and stabilize beer), and cookie baking (to improve
crispness), as well as the production of protein hy-
drolysates. Such preparations are currently employed
to produce many foods in which enzymes can replace
potentially carcinogenic or otherwise harmful chemi-
cals. Other applications are in tanning, in leather and
textile industries, to remove hair, wool, and to soften
skins (Uhlig, 1998).
Pharmaceutical applications of these endopepti-
dases have been made for ages, since the ancient use
of fig latex in digesting gastrointestinal nematodes
(Hansson et al., 1986) and the introduction of brome-
lain as a therapeutic compound in 1957: Its actions
include antitumor properties, immunity modulation,
digestive assistance, enhanced wound healing, and
cardiovascular and circulatory improvement, among
others, even when most of its mechanisms of action
are still not completely resolved (Kelly, 1996). By
their action as anti-inflammatory agents and increasing
the permeability of the blood–brain barrier to nutrients
and therapeutic agents, plant cysteine proteases, espe-
cially bromelain and papain, have shown certain
advantages for a perspective application in vivo
to Alzheimer’s disease patients (Krisˇtofiková and
Klaschka, 1999).
Enzymatic peptide synthesis, using proteases like
catalyst, is also a growing field in which the search for
endopeptidases is important. Enzymatic synthesis can
usually proceed very specifically, without racemization
and protection of reactant side-chains. The two main
advantages of enzymatic peptide synthesis are the high
specificity of the reaction and the absence of any side-
chain protection requisite. Among the various enzymes
studied, papain and ficin have proved to be versatile
biocatalysts for the synthesis of a great variety of
peptides (Barberis et al., 2000), as well as bromelain
(Clapés et al., 1995). The successful application
of these peptidases raises the possibility that other
cysteine proteases of plant origin could be used as
biocatalysts in peptide synthesis procedures.
The latex of the Asclepiadaceae plant family
usually contains proteases. Studies were made on
few genera such as Asclepias (Barragán et al., 1985;
Brockbank and Lynn, 1979; Carpenter and Lovelace,
1943; Greenberg and Winnick, 1940; Lynn et al.,
1980; Tablero et al., 1991; Winnick et al., 1940) and
Calotropis (Abraham and Joshi, 1979a, 1979b; Pal and
Sinha, 1980; Sengupta et al., 1984). Recently, some
cysteine proteases from plants belonging to this family
were purified and characterized in our laboratory from
the latex of Morrenia brachystephana and Morrenia
odorata (Arribére et al., 1998; Vairo Cavalli et al.,
2001, 2003), Araujia hortorum (Obregón et al., 2001;
Priolo et al., 2000), and Asclepias fruticosa (Trejo
et al., 2001). Following this trend, the purification and
characterization of funastrain c II, a protease isolated
from the latex of Funastrum clausum (Asclepiadaceae),
is described in this paper.
2. MATERIALS AND METHODS
2.1. Chemicals
Casein, AMPSO,4 CAPS, cysteine, E-64, EDTA,
MES, MOPS, L-pyroglutamil-L-phenylalanyl-L-leucine-
p-nitroanilide, p-nitrophenyl esters of N-α-carboben-
zoxy-L-amino acids, PMSF, TAPS, DTT, Tris, and
glycine were purchased from Sigma Chemical Company
(St. Louis, MO, USA). Coomassie Brilliant Blue R-250,
acrylamide, bisacrylamide, and low-molecular-weight
markers were obtained from Bio-Rad (Hercules, CA,
USA). SP-Sepharose Fast Flow and Pharmalyte 3-10
were purchased from Pharmacia (Biotech, Uppsala,
Sweden) All other chemicals were obtained from
commercial sources and were of the highest purity
available.
2.2. Plant Material
Stems of Funastrum clausum (Jacq.) Schlechter
[Latin synonym: Sarcostemma clausum (Jacq.) Roem.
& Schult] were obtained from plants grown in Rosario,
province of Santa Fe, Argentina (Argentinean folk
names: tasi, doca; English common name: white
twinevine). The plant is a vine with leaves narrowly
linear to broadly elliptic and white to greenish cream
flowers. Voucher specimens are deposited at the UNR
herbarium (Facultad de Ciencias Agrarias, Universidad
Nacional de Rosario, Argentina).
2.3. Purification of Funastrain c II
Latex was obtained by superficial incisions of
stems and collected on 0.1 M citric phosphate buffer
(pH 6.5) containing 5 mM EDTA and cysteine. This
suspension was first centrifuged at 16,000g for 30 min
at 4°C in order to discard gums and other insoluble
materials, and the supernatant was ultracentrifuged at
100,000g for 60 min at 4°C. The resulting supernatant
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containing soluble proteins, called “crude extract,” was
then applied onto a Pharmacia XK 16/40 column hav-
ing AK16 adaptors, packed with SP-Sepharose Fast
Flow and equilibrated with 55 mM citric phosphate
buffer (pH 6.5). The chromatography was developed in
an FPLC equipment (Pharmacia) by washing with the
equilibrating buffer and further elution of the bound ma-
terial with a sodium chloride linear gradient (0–0.5 M)
in the same buffer at a flow rate of 0.5 ml/min. Cation
exchange chromatography was monitored spectropho-
tometrically by absorption at 280 nm. Caseinolytic
activity was tested on the eluted fractions, and those
showing proteolytic activity were pooled and stored at
20°C for further studies.
2.4. Physical Characterization
2.4.1. Protein Determination
Measure of proteins was performed according to
Bradford assay method (Bradford, 1976) using BSA
as standard. The protein content of chromatography
eluates was estimated by absorbance at 280 nm during
separation.
2.4.2. Mass Spectrometry
Funastrain c II molecular weight and determina-
tion of its purity degree were determined by MALDI
TOF-MS. Equal volumes of protein solution and
MALDI matrix solution (saturated solution of sinap-
inic acid in 0.1% trifluoroacetic acid in water/acetoni-
trile 2:1) were mixed and 1 µl spotted on a stainless
steel target was allowed to air dry. Mass spectrum was
acquired on a MALDI-TOF MS Bruker Daltonics
model Ultraflex, (Billerica, MA, USA) equipped with
a N2 laser (337 nm), in the positive linear mode, at an
acceleration voltage of 25 kV. Bovine trypsinogen was
used for internal calibration.
2.5. Biochemical Characterization
2.5.1. Caseinolytic Activity Assay
Proteolytic activity was determined by the use of
casein as nonspecific substrate for crude extract and the
purified fraction, according to the method described
by Arribére et al. (1998). The amount of protease that
produces an increment of one absorbance unit per
minute in the assay conditions was considered as one
caseinolytic unit (Ucas) (Priolo et al. 1991).
2.5.2. Inhibition Assays
According to previous inhibition trials made on
the crude extract, the action of E-64 was proved by
incubating the enzyme with this inhibitor for 30 min at
45°C. Inhibition reversion was assayed by adding cys-
teine to the mixture and incubating for another 30 min
at the same temperature. The residual caseinolytic ac-
tivity was measured after each incubation as indicated
above.
2.5.3. Activation Assays
Cysteine and DTT were assayed as activators by
incubating funastrain c II with each activator for 10 min
at 45°C. Measurement of the resulting caseinolytic
activity after incubation was made to calculate the
increase due to activators.
2.5.4. Electrophoresis
2.5.4.1. SDS-PAGE. Homogeneity of funastrain
c II was assessed by SDS-PAGE with tricine cathodic
buffer in 10% polyacrylamide gels (Shägger and von
Jagow, 1987). Potential was kept constant at 40 mV for
the stacking gel and at 150 mV for the resolution gel.
The gels were stained with Coomassie Brilliant Blue
R-250 and scanned for the approximation of funastrain
c II molecular mass by using the Scion Image software.
For this purpose, protein molecular weight markers
(SDS-PAGE Molecular Weight Standards, Low Range,
Bio-Rad) were used as standards to generate the
calibration curve.
2.5.4.2. IEF and Zymogram. Funastrain c II iso-
electric point (pI) was determined by IEF, performed
in a Mini IEF Cell (Model 111, Bio-Rad). The deion-
ized sample was loaded onto a 5% polyacrylamide
gel with a 3–10 pH gradient (Biolyte 3-10 carrier
ampholytes, Bio-Rad), and the focusing of proteases
present in crude extract and the purified fraction was
performed according to the conditions 100 V for
15 min, 200 V for the following 15 min, and 450 V for
the last 60 min. One of the resulting gels was fixed and
stained with Coomassie Brilliant Blue R-250. The
zymogram was obtained after contacting the unstained
gel with an agarose one saturated in 1% casein solu-
tion in the presence of 12 mM cysteine for 20 min
at 56°C (Westergaard et al., 1980). Bands showing
proteolytic activity were detected after incubation by
dehydration and staining of the agarose gel with
Coomassie Brilliant Blue R-250.
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2.5.5. Dependence of Enzyme Activity on pH
Enzymatic activity dependence of funastrain c II
with pH was proved at 45°C with different substrates
using 10 mM sodium salts of the following “Good”
buffers: MES, MOPS, TAPS, AMPSO and CAPS
(Good and Izawa, 1972).
2.5.5.1. Using Casein as Substrate. Solutions of
1% casein with 12 mM cysteine were prepared at a
pH range from 6.0 to 11.0. Trials were performed as
indicated above.
2.5.5.2. Using PFLNA as Substrate. A stock so-
lution of 1 mM PFLNA in DMSO was prepared, and
0.3 M KCl, 104 M EDTA, and 0.003 M DTT were
added to the “Good” buffers, prepared at a pH range
from 6.0 to 8.0. The amidasic activity was measured
spectrophotometrically at 410 nm by the amount of
p-nitroaniline released by the hydrolysis of the sub-
strate after 3 min of incubation (Filippova et al., 1984).
2.5.6. Dependence of Enzyme Activity on Temperature
For testing proteolytic activity stability with tem-
perature, funastrain c II was incubated for different
times, ranging from 2 to 120 min, at 25, 45, 60, and
70°C. Residual caseinolytic activity was measured
under standard assay condition after stopping the re-
action in ice-water.
2.5.7. Kinetic Studies
2.5.7.1. Determination of Kinetic Parameters Using
N-CBZ-L-Ala p-Nitrophenyl Ester as Substrate. Kinetic
studies on esterolytic activity of funastrain c II were per-
formed at pH 9.0 and 45°C according to Silverstein
(1974). Concentrations of N-CBZ-L-Ala p-nitrophenyl
ester ranging from 0.01 to 0.125 mM in the mixture
reaction were proved. The absorbance of the released
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Fig. 1. Chromatographic isolation of funastrain c II. Crude extract
was applied to a SP-Sepharose fast flow column equilibrated with
0.05 M citric phosphate buffer pH 6.5. The unbound material was
eluted by washing with one column volume of the equilibrating buffer
(0.75 ml/min flow rate), and the bound proteins were eluted with a
linear gradient of 0–05 M NaCl in the same buffer (0.5 ml/min flow
rate). Fractions of 1.3 ml were collected. All the elution process was
monitored by absorbance at 280 nm (——). Caseinolytic activity was
measured on each fraction (- - - -).
Fig. 2. SDS-PAGE of crude extract and funastrain c II on 10%
polyacrylamide gel. References: lane 1, crude extract; lane 2,
funastrain c II; lane 3, molecular weight standards: phospho-
rylase b 97.4 kDa, serum albumin 66.2 kDa, ovalbumin 45.0
kDa, carbonic anhydrase 31.0 kDa, trypsin inhibitor 21.5 kDa,
and lysozyme 14.4 kDa. Proteins were stained with Coomassie
Brilliant Blue R-250.
p-nitrophenol was followed spectrophotometrically with
an Agilent 8453 E UV-visible spectroscopy system
(Palo Alto, CA, USA) at 405 nm every 10 s for 2 min.
An arbitrary enzyme unit (Ucbz), defined as the amount
of peptidase that released 1 µmol of p-nitrophenolate per
min in the assay conditions, was created to express the
esterolytic activity. A standard curve of p-nitrophenol
was performed to determine the micromoles produced
during the reaction. The resulting initial rates were
plotted against substrate concentration, and kinetic
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Table 1. Purification Table of Funastrain c II
Protein Total Specific Purification
Sample Volume (ml) (mg/ml) proteins (mg) Ucas/ml Total Ucas activity (Ucas/mg) (fold) Yield (%)
Crude extract 2.5 0.551 1.3375 0.775 3.514 1.41 — —
Funastrain c II 14 0.024 0.3416 0.182 2.548 7.45 5 24.8
Ucas, caseinolytic unit.
Fig. 3. Mass spectrometry of funastrain c II. Sample was prepared by mixing equal volumes of protein solution and MS matrix
solution and introduced in MALDI-TOF MS equipment. Peaks at m/z above MH (23,634 Da) correspond probably to matrix
adducts.
parameters (Km and Vm) were calculated by nonlinear
fitting using the Origin 6.0 software as well as the
Lineweaver-Burk transformation.
2.5.7.2. Determination of Kinetic Parameters Using
PFLNA as Substrate. Initial rates of hydrolysis were
measured spectrophotometrically at 410 nm according to
Filippova et al. (1984) at pH 6.5 and 45°C for concen-
trations of PFLNA ranging from 0.01 to 0.5 mM in the
reaction mixture. The amidolytic activity was expressed
in an arbitrary enzyme unit (UPFLNA), defined as the
amount of peptidase that released 1 µmol of p-nitroani-
line. Km and Vm were calculated as indicated above.
2.5.8. N-Terminal Sequence
A lyophilized sample of funastrain c II was de-
salted by resuspension in 0.1% TFA, immobilization
on a PVDF membrane on a centrifugal device (MIL-
LIPORE, Billerica, MA, USA), followed by thorough
washing with water. Determination of the N-terminal
sequence was achieved by Edman’s automated
degradation in a Beckman LF3000 Protein Sequencer
equipped with a System Gold (Beckman, Munich,
Germany) PTH-aminoacid analyzer. The PSI BLAST
2.1 (Altschul et al., 1997; Schaffer, 1999) and BLAST
2 (Tatusova and Madden, 1999) network service
(http://www.ncbi.nlm.nih.gov/blast; http://embnet.cifn.
unam.mx/blast/wblast2.html) were used to perform the
protein homology studies by comparing with those in
the Swiss Prot database and the N-terminus of those
purified in our laboratory.
3. RESULTS AND DISCUSSION
The purification of funastrain c II from the latex
of Funastrum clausum (Jacq.) Schlechter was achieved
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Fig. 4. IEF an zymogram of funastrain c II and crude extract. References: IEF lane 1, isoelectric point markers:
amyloglucosidase from Aspergillus niger 3.6, trypsin inhibitor from soybean 4.6, β-lactoglobulin A from bovine
milk 5.1, carbonic anhydrase II from bovine erythrocytes 5.9, carbonic anhydrase I from human erythrocytes 6.6,
myoglobin from horse heart 6.8, 7.2, lectin from Lens culinaris 8.2, 8.6, 8.8, trypsinogen from bovine pancreas
9.3; lane 2, funastrain c II; lane 3, crude extract. Zymogram: lane 4, crude extract; lane 5, funastrain c II.
by a two-step procedure. Centrifugation of the latex
followed by further ultracentrifugation yielded the
crude extract, which was further applied onto a SP-
Sepharose column chromatograph. The elution profile
is shown in Fig. 1. The unbound eluate manifested ac-
tivity toward casein, as well as the two fractions eluted
after the application of the linear NaCl gradient. The
second peak showing proteolytic activity, eluted at 0.45
M NaCl, was selected for the current study, due to its
high specific activity (Table 1) and to its purity, proved
by SDS-PAGE and MS (Figs. 2 and 3). The name fu-
nastrain c II for this endopeptidase was chosen ac-
cording to previous suggestions (Barragán et al., 1985;
Tablero et al., 1991).
Funastrain c II molecular mass obtained by SDS-
PAGE was 23.6 kDa, whereas by MS it was 23.636 kDa.
Both techniques showed a good coincidence in their
results. The molecular mass of funastrain c II was sim-
ilar to those indicated for cysteine proteases from
Asclepiadaceae (Vairo Cavalli et al., 2003) and lying
in the range of 20–35 kDa reported for most of the plant
cysteine proteinases (Turk et al., 1997). As SDS-PAGE
was performed in reducing conditions, the appearance
of a single band revealed the monomeric nature of the
enzyme (Fig. 2).
Isoelectric focusing and zymogram evidenced the
basic characteristic of funastrain c II (pI higher than
9.3; Fig. 4), in agreement with those obtained for other
peptidases from the Asclepiadaceae family latex (Trejo
et al., 2001).
The cysteine residue involved in the catalytic site
of the purified enzyme was manifested by the inhibition
with 10 µM E-64 and by activation with reducing agents
such as 12 mM cysteine and 5 mM DTT. E-64 reduced
the initial caseinolytic activity of funastrain c II to a half
after 30 min of incubation; the addition of 12 mM
cysteine to revert inhibition and the further incubation
with the inhibitor for other 30 min resulted in the
complete inactivation of the enzyme, demonstrating that
E-64 reacted specifically with the active site of the
protease (Barret et al., 1982), and inhibited it even in
the presence of reducing agents used to activate cys-
teine proteases (Salvesen and Nagase, 2001). Because
E-64 is quite a selective inhibitor for the “papain-like”
cysteine endopeptidases, the obtained results could ev-
idence that funastrain c II would be a protease related
to papain (Barret et al., 1998). In opposition to the crude
extract behavior (data not shown), the presence of an
activator was essential to demonstrate the caseinolytic
activity of funastrain c II: cysteine and DTT enhanced
the catalytic activity of the enzyme up to 25-fold.
The optimum pH for funastrain c II activity varied
according to the substrate used for its determination.
Cysteine Endopeptidase from Funastrum clausum Latex 211
Fig. 5. Determination of optimum pH of funastrain c II toward
casein (——) and PFLNA (- - - -) as substrates, using the “Good”
buffers. Proteolytic and amidolytic activities were measured in each
case at 280 nm and 410 nm, respectively.
Fig. 6. Funastrain c II thermal stability. Residual caseinolytic ac-
tivity of funastrain c II was measured after incubating solutions of
the purified enzyme at 25, 45, 60, and 70°C. Samples were taken
after 2, 5, 10, 20, 40, 60, and 120 min of incubation, and the activ-
ity toward casein was determined.
For the natural substrate casein, the optimum pH
for which the activity was more than 90% of the max-
imum was in the range of 9.0–10.0; the sharp profile
shown in Fig. 5 is different to the broad pH range
obtained for other plant thiol proteases (Dubey and
Jagannadham, 2003). However, the caseinolytic activ-
ity was still retained up to more than 50% of the initial
rate at pH values as extreme as 6.0 and 11.0. The
enzymatic cleavage of the synthetic substrate PFLNA
showed its maximum in the pH range of 6.2–6.8, in
concordance with those obtained for other cysteine pro-
teases such as papain and bromelain (Filippova et al.,
1984).
As can be seen in Fig. 6, the thermostability of
funastrain c II was proved to be higher than 60% up to
2 hr of incubation at all the tested temperatures. This
behavior has also been demonstrated for the crude
extract (data not shown). Other cysteine proteases from
latices of Asclepiadaceae, as the purified protease
morrenain b II from Morrenia brachystephana, showed
a similar performance (Vairo Cavalli et al., 2003).
The knowledge of such parameters as optimum pH and
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Table 3. Comparison of the Values of Kinetic Parameters Obtained for Different Asclepiadaceae Endopeptidases Toward
N-CBZ-Ala p-Nitrophenyl Ester
Enzyme Funastrain c II Morrenain b I Morrenain b II Morrenain o II
Km 0.0243 mM 0.0200 mM 0.0410 mM 4.3×105 mM
kcat/Km 6.1×104 s1 M1 1.7×105 s1 M1 1.6×105 s1 M1 1.7×108 s1 M1
Table 2. Kinetic Parameters Obtained for Funastrain c II Toward Synthetic Substrates
Substrate Km Vm kcat kcat/Km
N-CBZ-Ala p-nitrophenyl ester 0.0243 mM 2.3 µmol min1 1.5 s1 6.1×104 s1 M 1
PFLNA 0.1011 mM 9.2 µmol min1 0.9 s1 8.5×103 s1 M 1
PFLNA, L-pyroglutamyl-L-phenylalanyl-L-leucine-p-nitroanilide.
Fig. 7. Substrate (N-CBZ-L-Ala p-nitrophenyl ester) concentration
effect on funastrain c II initial velocity. Absorbance increase at
405 nm versus time was measured spectrophotometrically and
velocity was expressed as UCBZ. Inset: Lineweaver-Burk plot. Km
and Vm were calculated according to Michaelis–Menten equation
(by fitting the data with the Origin 6.0 software) and from the
Lineweaver-Burk plot.
Fig. 8. Substrate (PFLNA) concentration effect on funastrain c II
initial velocity. Absorbance increase at 410 nm versus time was mea-
sured spectrophotometrically and velocity was expressed as UPFLNA.
Inset: Lineweaver-Burk plot. Km and Vm were calculated according
to Michaelis–Menten equation (by fitting the data with the Origin
6.0 software) and from the Lineweaver-Burk plot.
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Table 4. BLAST for Funastrain c II
Protein and source N-terminal sequence Identities % Positives % References
Funastrum clausum
Funastrain c II
Asclepias fruticosa
Asclepain f
Asclepias syriaca
Asclepain a
Asclepain b
Araujia hortorum
Araujiain h III
Oriza sativa
Oryzain beta chain precursor
Hordeum vulgare
Cysteine proteinase EP-B 2 precursor
Cysteine proteinase EP-B 1 precursor
Rattus norvegicus
Cathepsin J precursor (cathepsin L-related protein)
Sus scrofa
Cathepsin L precursor
Morrenia brachystephana
Morrenain b II
Morrenia odorata
Morrenain o II
Homo sapiens
Cathepsin L precursor
Carica papaya
Papain precursor (papaya proteinase I)
Caricain precursor (papaya proteinase omega)
Mus musculus
Cathepsin L precursor
31/31 (100%)
17/21 (80%)
15/20 (75%)
15/21 (71%)
22/31 (70%)
21/31 (67%)
21/31 (67%)
21/31 (67%)
21/31 (67%)
20/30 (66%)
15/23 (65%)
15/23 (65%)
19/29 (65%)
20/31 (64%)
20/31 (64%)
19/30 (63%)
—
19/21 (89%)
17/20 (85%)
17/21 (80%)
26/31 (82%)
26/31 (83%)
25/31 (80%)
25/31 (80%)
25/31 (80%)
26/30 (86%)
19/23 (82%)
19/23 (82%)
24/29 (82%)
25/31 (80%)
25/31 (80%)
25/30 (83%)
Present paper
Trejo et al., 2001
Lynn et al., 1980
Lynn et al., 1980
Obregón et al., 2001
Watanabe et al., 1991
Koehler and Ho, 1990
Koehler and Ho, 1990
Conliffe et al., 1995
Okamura et al., 1995
Vairo et al., 2001
Vairo et al., 2001
Joseph et al., 1988
Mitchell et al., 1970
Dubois et al., 1988
Portnoy et al., 1986
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LPSVDWRK V RNQGK G
LPDSVDWRKKNLVFPVRNQGKKG
LPSVDWRK V RNQGK G
LPDSVDWRKKNLVFPVRNQGKXG
P  SVDWRKG V NQGCGSC AF  A
PRSVDWREKGYVTPVKNQGQCGSCWAFSA
LP VDWRKG V RQG CGSC AF AV
LPENVDWRKKGAVTPVRHQGSCGSCWAFSAV
LP VDWRKG V RQG CGSC AF AV
LPENVDWRKKGAVTPVRHQGSCGSCWAFSAV
P SVDWRKG V NQGCGSC   AF A
IPKSVDWREKGCVTPVKNQGQCGSCWAFSA
thermal stability are necessary to explore funastrain
c II potential applications in the food and pharmaceu-
tical industries.
Kinetic parameters (Km, Vm, and kcat) were deter-
mined for esterolytic and amidolytic activities
(Table 2). The N-CBZ-p-nitrophenyl ester derivative of
Ala was chosen for the former determinations due to the
high preference showed by the crude extract (unpub-
lished). For the latter, PFLNA was used. Because the
kcat/Km ratio is considered the best kinetic quantity to
express catalytic efficiency, the comparison of this
parameter obtained for funastrain c II and other Ascle-
piadaceae proteases purified in our laboratory is shown
in Table 3; the comparison of Km values was also taken
into account. For both kinetic values, funastrain c II
showed a remarkable similitude with those obtained
from morrenain b I and morrenain b II (Vairo Cavalli
et al., 2001, 2003). The comparison of PFLNA Km val-
ues for funastrain c II and those for papain, ficin, and
bromelain (Filippova et al., 1984) revealed that the one
obtained for the peptidase studied in the current work
is three times higher than the others. Km and Vm calcu-
lations were made by using the Origin 6.0 software and
the Lineweaver-Burk transformation, and the results
obtained in both cases were coincident (Figs. 7 and 8).
The N-terminal sequence of funastrain c II was
compared with those of other proteases (Table 4). From
the homology results, the undefined residues for the
26 and 29 positions were considered to be Trp and Ser,
respectively, so the definitive sequence should be
LPNSVDWRQKGVVSAIRNQGKCGSCWAFSAV.
A remarkable similarity (80% identities) between the
purified protease and asclepain f N-terminus can be ob-
served, as well as with those of asclepains a and b (75%
and 71% identities, respectively), indicating that there
could be a close evolutive relation among Funastrum
and Asclepias genera. The high correspondence showed
by funastrain c II N-terminus with others belonging to
different cysteine proteases included in the clan CA,
family C1, according to the Merops system for the clas-
sification of peptidases (Barret, 2001), indicates that
the purified endopeptidase would be closely related to
papain. The presence of a Cys in the 25 position could
correspond to the Cys residue of the catalytic site. This
evidence is reinforced by the presence of a Gln residue
in the 19 position, essential for catalytic activity by
helping the catalytic triad in the formation of the
“oxoanion hole”; an electrophilic center that stabilizes
the tetrahedral intermediate. The hydrophobic and
aromatic amino acids (Trp26, Ala27, and Phe28, in our
case) following the catalytic Cys consist of a usual
characteristic of the proteases belonging to this family
(Barret et al., 1998). The existence of Pro2 is also a
common feature in the mature proteases of family C1,
and it is suggested that this prevents attack by
aminopeptidases, due to the resistance offered by the
Xaa-Pro bond to such enzymes (Barret et al., 1998).
On the whole, all the characteristics found for fu-
nastrain c II, such as the alkaline nature, its molecular
weight, the optimum pH enzymatic activity toward dif-
ferent substrates, the inhibition by E-64 and activation
by reducing agents, the high thermal stability, and the
kinetic parameter values (especially those calculated
for PFLNA), showed that the purified endopeptidase
could belong to the “papain-like” family of proteases.
This hypothesis would be confirmed by the analysis of
its N-terminal amino acid sequence and its comparison
with those similar ones, all of them members of the
mentioned family of cysteine peptidases.
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